Livzon Pharmaceutical Group Inc. (SZSE:000513) announces a share repurchase program. Under the program, the company will repurchase up to CNY 600 million worth of its class A shares. The program will be valid for a period of 12 months.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.3 CNY | -0.79% | -0.44% | +15.11% |
05-14 | Livzon Pharmaceutical Group Cancels Share Options | MT |
05-14 | Livzon Pharmaceutical Declares Final Dividend for 2023 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.11% | 4.62B | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Livzon Pharmaceutical Group Inc. announces an Equity Buyback for CNY 600 million worth of its shares.